SCHEMBL11348762

SCHEMBL11348762

O=[N+]([O-])c1nccn1CC(O)CNCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.60
CYP2D6 P10635 1/20 0.60
OPRK1 P41145 1/20 0.60
KMT2A Q03164 2/20 0.54
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
DNM1 Q05193 4/20 0.46
CA12 O43570 4/20 0.44
CA1 P00915 4/20 0.44
CA2 P00918 4/20 0.44
CA9 Q16790 4/20 0.44
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.41
CYP2C19 P33261 1/20 0.41
BCHE P06276 1/20 0.39
MEN1 O00255 1/20 0.38
CTSB P07858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11390701 0.99 CYP3A4 (0.58) CYP3A4CYP2D6OPRK1KMT2AKDM4E
SCHEMBL11465450 0.82 CYP3A4 (0.55) CYP3A4CYP2D6OPRK1KMT2AKDM4E
Iodide SCHEMBL9190400 0.81 KMT2A (0.58) CYP3A4CYP2D6OPRK1KMT2ACA12
SCHEMBL9085514 0.81 KMT2A (0.58) CYP3A4CYP2D6OPRK1KMT2AKDM4E
SCHEMBL8855559 0.80 KMT2A (0.57) CYP3A4CYP2D6OPRK1KMT2AALDH1A1
SCHEMBL367445 0.80 KMT2A (0.57) CYP3A4CYP2D6OPRK1KMT2ACA12
SCHEMBL8855458 0.80 KMT2A (0.57) CYP3A4CYP2D6OPRK1KMT2ACA12
SCHEMBL8855564 0.80 KMT2A (0.57) CYP3A4CYP2D6OPRK1KMT2ACA12
SCHEMBL8895125 0.80 KMT2A (0.57) CYP3A4CYP2D6OPRK1KMT2ACA12
SCHEMBL8895890 0.80 KMT2A (0.57) CYP3A4CYP2D6OPRK1KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0000928-B1 NITROIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS WELL AS THEIR PREPARATION F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-03-18 EP claimed
US-4241060-A FOR SENSITIZING HYPOXIC CELLS TO RADIATION; ANTIPROTOZAL AGENTS HOFFMANN-LA ROCHE INC. (US) 1980-12-23 US claimed
EP-0000928-A1 Nitroimidazoles and pharmaceutical compositions containing them as well as their preparation F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1979-03-07 EP claimed
EP-0000928-B1 NITROIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS WELL AS THEIR PREPARATION F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-03-18 EP disclosed
US-4241060-A FOR SENSITIZING HYPOXIC CELLS TO RADIATION; ANTIPROTOZAL AGENTS HOFFMANN-LA ROCHE INC. (US) 1980-12-23 US disclosed
EP-0000928-A1 Nitroimidazoles and pharmaceutical compositions containing them as well as their preparation F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1979-03-07 EP disclosed